Sandoz layoffs continue as Broomfield plant closes
BROOMFIELD — Sandoz Inc. announced this week that 37 more employees will be laid off as Novartis-affiliated pharmaceutical company winds down operations at its Broomfield manufacturing plant.
The latest employee separations — part of a rolling series of layoffs in advance of the facility closure that will result in the loss of about 450 jobs — are expected to occur between October and December, according to a Worker Adjustment and Retraining Notification Act notice submitted to the Colorado Department of Labor and Employment.
These upcoming layoffs will affect employees in a variety of job types, including analysts, associate directors, chemists, production managers and scientists.
SPONSORED CONTENT
That 400,000-square-foot Sandoz campus at 2555 W. Midway Blvd. was sold in June to CBD manufacturer Mile High Labs Inc. for $18.8 million. Mile High has gradually moved employees and equipment into the Broomfield facility while Sandoz, which is now leasing back space from the hemp product maker, closes up shop.
BROOMFIELD — Sandoz Inc. announced this week that 37 more employees will be laid off as Novartis-affiliated pharmaceutical company winds down operations at its Broomfield manufacturing plant.
The latest employee separations — part of a rolling series of layoffs in advance of the facility closure that will result in the loss of about 450 jobs — are expected to occur between October and December, according to a Worker Adjustment and Retraining Notification Act notice submitted to the Colorado Department of Labor and Employment.
These upcoming layoffs will…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!